INTRODUCTION
Oral route is the most convenient route of drug administration. Several marketed drugs and New Chemical Entities (NCEs) are poorly soluble in aqueous media leading to problems in absorption from the gastrointestinal tract after oral administration. Penetration of these kinds of compounds via intestinal mucosa can be enhanced using absorption enhancers, which can increase the bioavailability and efficacy of a drug candidate [1] .
There are several permeability enhancers which can help compounds to permeate through the intestinal barriers. These enhancers are surfactants, fatty acids, medium chain glycerides, steroidal detergents, acyl carnitine and alkanoylcholines, N-acetylated α-amino acids and Nacetylated non-α-amino acids, and chitosans and other mucoadhesive polyers [2] . Usage of permeability enhancers brings concerns of toxicity either in the GIT epithelium (in vivo) or disruption to the cell monolayer upon exposure (in vitro) [3] . This investigation aims to address and investigate the optimal levels of permeability enhancers which don't cause any damage to the cell monolayer [4] .
To investigate the mechanisms involved in the bioavailability after oral administration Caco-2 monolayer model of epithelial cells have been widely used to study active and passive transport of drug molecules [5] . Caco-2 cell line is derived from a human colorectal carcinoma and these cells strongly express P-gp transporter [6] . Because of their tumorous nature this cell system is widely used in in vitro screening technologies to predict gastrointestinal absorption and possible Pgp transport of NCE's [7] . This model is also acceptable to FDA for in vitro evaluation of permeability for BCS Classification of drugs [8] and also for evaluating NCEs as a substrates and inhibitor of Pglycoprotein (P-gp, MDR1).
Caco-2 cells when cultured on semi permeable membranes differentiate into a highly functionalized epithelial barrier and forms tight junctions with remarkable morphological and biochemical similarity to the small intestinal columnar epithelium [9] . The membrane transport properties of novel compounds can thereby be assessed using this differentiated cell monolayer. The apparent permeability coefficients (Papp) obtained from Caco-2 cell transport studies have been shown to correlate to human intestinal absorption.
This investigation will approach to summarize the optimal levels of absorption enhancer which do not cause any toxic effect on Caco-2 cell monolayer.
MATERIALS AND METHODS

Chemicals and apparatus
Dulbecco's Modified Eagles medium (DMEM) (Cat # D5671), trypsin-EDTA solution (Cat # T3924), Fetal Bovine Serum (FBS) (Cat # 12003C), Hanks Balanced salt solution HBSS (Cat # H6648), Lucifer yellow (L0529) and Loperamide (Cat # L4762) were purchased from Sigma, Germany.
3-(N, N-Dimethylpalmitylammonio) propanesulfonate (PPS), Cremphore EL and Peanut oil were purchased from Sigma, USA. T-75 flasks and serological pipettes were purchased from Grenier-Bio-one, Germany. Mill cell -24 well PET membrane 1µm plates (Cat # PSRP010 R5) were purchased from Millipore
Cell culture
Caco-2 cells were procured from National Center for Cell Sciences (NCCS), Pune, India. The Caco-2 cells were cultured in DMEM supplemented with 10% FBS and 2% penicillin-streptomycin in a 37
• C with 5% CO 2 humidified incubator. The cells were harvested at approximately 80-90% confluency using 0.25% trypsin-EDTA (Ethylenediaminetetraacetic acid). The cells (passage number # 36) were then seeded onto transwell inserts at a density of 0.8 x 10 5 cells/cm 2 and grown for 21 days. Medium was changed every alternative days and 100% confluent monolayer of cells on the inserts was used for transport assays. The formation of confluent monolayers and tight junctions was tested and confirmed by measuring transepithelial electrical resistance (TEER) across the cell monolayers from day 15 onwards.
Dosing solutions preparations of permeability enhancer
Different percentages of permeability enhancers are prepared as described below and shown in table 1.
 Capmul was weighed and liquefied at 45ºC in water bath for 10 min to prepare 10% stock in HBSS (Hanks Balanced salt solution). These were further diluted to 1%, 0.1% and 0.01% using HBSS.
 Cremophore EL, glycerol, Labrasol, MC8-2, Miglyol 812, Oleic acid, Peanut oil, PEG 400, Polysorbet 80, Propylene glycol and transcutol was added to HBSS buffer to prepare 10% stock, which were further diluted to 1% and 0.1% using HBSS.
 PPS was weighed and stock of 1% is prepared in HBSS. These were further diluted to 0.01%, 0.001% and 0.0001% using HBSS.
 Spiriol TPGS, Solutol and Capmul MCM C8 was weighed and liquefied at 45ºC in water bath for 10 min to prepare 10% stock in HBSS. These were further diluted to 1% and 0.1% using HBSS.
Measurement of TEER
The TEER test was performed using a Millicell ERS voltommeter, following equation was used to calculate the TEER values (Ω cm 2 ) across the cell monolayers:
Where, R is the measured resistance across a cell monolayer, R blank is the resistance of a blank well and A is the surface area of the transwell filter (0.7cm 2 ) . TEER values were measured and wells showing TEER values above 230 Ω cm 2 were taken for experiments, indication of formation of a cell monolayer with tight junctions. TEER values were also measured at the end of assay (120 min) to assess the toxic effects of permeability enhancers on the cell membrane's integrity. 
Lucifer Yellow (LY) Rejection Assay
Lucifer yellow travel across cell monolayer only through paracellular diffusion and has low permeability. As a result it's not possible to cross cell monolayer when tight junctions are well maintained. The integrity of the monolayer was measured by monitoring the lucifer yellow rejection, a paracellular marker across cell monolayer.
LY fluorescence (RFU) was measured at 485/535nm and the percent rejection of LY was calculated using formula:
Where, RFU is relative fluorescence units. After the completion of last time point sampling (120 min), 100 µL samples from apical and basal compartment was measured for lucifer yellow RFU. The % LY rejection values > 99% suggests the integrity of monolayer was maintained within duration of experiment. Dosing solutions for different percentage of permeability enhancers prepared in HBSS were added on apical side of monolayer (A→B transport) followed by adding 800 µL of HBSS on basal side. After completion of experiment (120 min) samples were collected from apical and basal compartment for Lucifer Yellow Rejection followed by post experiment TEER values.
Transport studies
To assess the functionality of P-glycoprotein (P-gp) on Caco-2 cell monolayer loperamide was run as a positive control at 5µM concentration (A→B / B→A; pH 7.4 / 7.4), study will be initiated by adding 400 µL of loperamide prepared in HBSS in apical (A→B transport) followed by addition of 800 µL of HBSS on basal side and for B→A transport 800 µL of loperamide prepared in HBSS will be dosed in basal followed by addition of 400 µL HBSS on apical side. At selected time points (0, 30, 60 and 120 minutes) an aliquot of 50 µL will be collected from the receiver compartment for determination of test compound concentrations. The volume withdrawn will be replaced immediately with HBSS buffer. 50 µL aliquot of test samples collected at respective time points were diluted with acetonitrile containing suitable internal standard were vortexed for 5 minutes and 100 µL will be transferred to insert vials and analyzed using LC-MS/MS. Lucifer Yellow Rejection and TEER will be measured at the end to the experiment to confirm any damage of monolayer while performing experiment.
Data Analysis
The apparent permeability (P app ) (A→B and B→A) of test compounds and positive control will be calculated using the following formula:
Where, dQ/dt -linear slope of test compound concentration in receptor chamber with time (0, 30, 60 and 120 min) after correcting for dilution.
A -Area of the filter (0.7 cm 2 ); C o -Initial concentration of compound in the donor compartment.
Efflux ratio (R E ) will be calculated using the following equation:
Where P B/A and P A/B represent the apparent permeability of test compound from the basal to apical and apical to basal side of cell monolayer. The compounds having efflux ratio of > 2 is considered as having potential for P-gp substrate.
RESULTS
Bi-directional transport of loperamide in Caco-2 cells
Bi-directional transport of loperamide was performed to assess the functionality of P-glycoprotein (P-gp) on Caco-2 cell monolayer. Apparent permeability coefficients (Papp) of Loperamide were calculated to assess the functionality of P-glycoprotein (P-gp) on Caco-2 cell monolayer is 5.04 x 10 -6 cm/sec for A→B transport and 16.6 x 10 -6 cm/sec for B→A transport. Papp values for bi-directional transport of loperamide are shown in Table1. Loperamide showed an efflux ratio of 3.3 confirming that P-gp is active in cell monolayer evident from Table 2 and Fig.1 . The efflux ratio obtained with loperamide transport is within range as reported 10 . (5µM) showed an efflux ratio of 3.3 which dropped down to 0.9 in presence of P-gp inhibitor verapamil (100µM) 
Inhibition studies of loperamide with verapamil across Caco-2 cells
Addition of verapamil (100µM) to both compartments diminishes the P-gp mediated efflux. Inhibitory effect produced is observed through a decrease in loperamide B→A transport and an increase in A→B transport. Verapamil (100µM) significantly inhibited the loperamide B→A transport and improved A→B transport. The change in Papp values is depicted in Table 2 and Fig. 1 . A→B and B→A Papp values for loperamide transport after addition of verapamil was found to be 14.6 x 10 -6 cm/sec and 13.7 x 10 -6 cm/sec, respectively. After addition of P-gp inhibitor loperamide showed an efflux value of 0.9 confirming that P-gp is active in cell monolayer.
TEER measurements
TEER measurements were made both prior to and at the end of experiment as drop in TEERs indicating the opening of tight junctions which might be due to toxicity caused by usage of various percentages of permeability enhancers, as evident in Fig. 2-17. 
% LY rejection values
Monolayer integrity was tested by Lucifer yellow (LY) rejection, percent rejection of LY was calculated and the various percentages of permeability enhancers showing values < 99% are considered to have toxic effect on Caco-2 cell monolayer, as evident in Fig. 2-17 . 
DISCUSSION
Compiling the data generated by pre and post TEER measurement and leak test using Lucifer yellow (LY) rejection assay as evident in Fig. 18 , the ideal levels of permeability enhancer which is not toxic to cell monolayer are as per parenthesis: peanut oil (10%), Cremphore EL, 
CONCLUSION
This article addresses the optimum levels of commonly used permeability enhancers in Caco-2 cell lines to predict the oral bioavailability These enhancers generally increases the intestinal membrane permeability which is similar to Caco-2 cell monolayer permeability. The critical issue considered in evaluating this approach is the toxic effect and damage of cell monolayer by the usage of permeability enhancers. The categories of permeation enhancers discussed are surfactants, fatty acids, medium chain glycerides, steroidal detergents, acyl carnitine and alkanoylcholines, N-acetylated α-amino acids and Nacetylated non-α-amino acids, and chitosans and other mucoadhesive polyers. This can be a potential approach in selecting appropriate enhancer to improve oral bioavailability of poorly absorbed compounds. This will reduce the attrition during in vivo assessment of oral bioavailability improvement.
